|
ISRTP |
|
2009
Endocrine Workshop
The Endocrine Disruptor Screening Program:
What Can Screening Results Tell Us About Potential Adverse Endocrine Effects?
September 9-10, 2009
Lister Hill Center Auditorium
(NIH Building 38A)
National Institutes of Health
Bethesda, MD
TWO-DAY PROGRAM
| DAY 1 - SEPTEMBER 9, 2009 | |
|
8:00 - 9:00 |
Registration and Continental Breakfast |
|
9:00 - 9:30 |
Welcome and Workshop Overview
|
|
|
|
| 9:30 - 9:45 |
Session Introduction Angelina Duggan, Exponent (Moderator) SLIDES AUDIO |
| 9:45 - 10:05 |
EDSP Battery and Status
Gary Timm, EPA SLIDES AUDIO |
|
10:05 - 12:15
|
Panel Presentations and Discussion |
| 10:25 - 10:45 | BREAK |
| 10:45 - 12:15 |
|
| SESSION 1 PANEL DISCUSSION AUDIO | |
| 12:15 - 1:00 |
LUNCH |
| 1:00 - 1:40 |
KEYNOTE |
|
SESSION II Incorporating Existing Data into the EDSP |
|
| 1:40 - 1:55 |
Session Introduction
|
| 1:55 - 2:15 |
What Current Information
Fulfills the Needs of EDSP Screening?
|
| 2:15 - 2:35 |
What Can EDSP Screening Tell Us That the FIFRA Test Guidelines Cannot?
James T. Stevens, Wake Forest University School of Medicine SLIDES AUDIO |
| 2:35 - 2:55 |
BREAK |
| 2:55 - 4:10 |
Panel Presentations and Discussion |
| 4:10 - 4:55 |
KEYNOTE |
| 5:00 - 7:00 |
RECEPTION |
|
DAY 2 - SEPTEMBER 10, 2009 |
|
| 8:00 - 9:00 | Registration and Continental Breakfast |
| 9:00 - 9:15 |
Day Two Introduction
AUDIO Terry Quill, Quill Law Group LLC |
|
SESSION III Point - Counterpoint Assessing Cumulative Effects of Endocrine Active Substances |
|
| 9:15 - 9:30 |
Session Introduction
|
| 9:30 - 10:00 |
Techniques For Assessing Endocrine Cumulative Risk
|
| 10:00 - 10:30 |
Limitations of EDSP Data For Assessing Cumulative Risk
Christopher Borgert, Applied Pharmacology and Toxicology Inc. SLIDES AUDIO |
| 10:30 - 11:45 | Panel Presentations and Discussion |
| SESSION 3 PANEL DISCUSSION AUDIO | |
| 11:45 - 12:30 |
LUNCH |
|
|
|
| 12;30 - 12:45 |
Session Introduction |
| 12:45 - 1:05 |
Correlation of Genomic Methods With
In Vivo Studies
|
| 1.05 - 1:25 |
21st Century Screening Assessment of Pesticides – An Agency View
|
| 1:25 - 1:40 |
What Can ToxCast Tell Us About Endocrine Disruption?
Keith Houck, EPA Center for Computational Toxicology SLIDES AUDIO |
| 1:40 - 1:55 |
Ethical Considerations and Alternative Testing Methods
Troy Seidle, The Humane Society SLIDES AUDIO |
| 2:10 - 2:40 | SESSION 4 PANEL DISCUSSION AUDIO |
| 2:40 - 3:00 |
BREAK |
|
SESSION V EDSP Implementation – Legal and Regulatory Considerations |
|
| 3:00 - 3:15 |
Session Introduction
|
| 3:15 - 3:35 |
EPA’s Implementation of EDSP Screening
Bill Jordan, EPA SLIDES AUDIO |
| 3:35 - 3:55 |
Legal and Regulatory Issues Related to EDSP Implementation
Terry Quill, Quill Law Group LLC SLIDES AUDIO |
| 3:55- 5:00 |
Panel Presentations and Discussion |
| SESSION 5 PANEL DISCUSSION AUDIO | |
| 5:00 | ADJOURN |